Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale
Endpoints
Mon, 03/12/18 - 09:38 am
Tags:
Biogen, schizophrenia, clinical trials, Pfizer, PF-04958242
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Endpoints
Fri, 03/2/18 - 11:08 am
Tags:
Biogen, AbbVie, MS, multiple sclerosis, Zinbryta, Europe, encephalitis
What's beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two
Fierce Pharma
Mon, 02/26/18 - 11:30 am
Tags:
drug launches, hepatitis C, Ibrance, Tecfidera, Biogen, Pfizer, Gilead Sciences
Biogen’s key Alzheimer’s disease drug is facing potential signs of trouble
Marketwatch
Sun, 02/18/18 - 10:12 am
Tags:
Biogen, Alzheimer's disease, aducanumab
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
Tags:
AbbVie, Allergan, Roche, Biogen, UCB Pharma, Acorda Therapeutics, M&A
Biogen tweaks Alzheimer’s phase 3, sparking stock slide
Fierce Biotech
Thu, 02/15/18 - 09:39 am
Tags:
Biogen, Alzheimer's disease, clinical trials, aducanumab
Top 10 most productive workforces in biopharma
Fierce Pharma
Mon, 02/12/18 - 11:03 am
Tags:
Pharma, pharma employees, productivity, Gilead Sciences, Celgene, Pfizer, AbbVie, Biogen
Biogen to Discontinue Development of Stroke Drug After Early-Stage Trial Failure
Xtalks
Thu, 02/8/18 - 10:11 am
Tags:
Biogen, stroke, clinical trials, natalizumab
Biogen scuttles a Tysabri program after the drug fails stroke test, thinning the pipeline
Endpoints
Wed, 02/7/18 - 10:03 am
Tags:
Biogen, Tysabri, ischemic stroke
Biogen Inc. Caps Off a Solid 2017, Waits on Aducanumab
Motley Fool
Mon, 01/29/18 - 11:56 pm
Tags:
Biogen, aducanumab, earnings
Why big pharma companies always create new spinoffs
GoinPharma
Sun, 01/28/18 - 10:06 am
Tags:
spinoffs, Sanofi, Celgene, Biogen, AbbVie, Abbott Labs, Baxalta, Shire
Biogen's in the hunt for late-stage assets, executives say amid Q4 revenue beat
Fierce Pharma
Fri, 01/26/18 - 09:35 am
Tags:
Biogen, earnings, M&A
Biogen: Where Is That Blockbuster Acquisition?
Forbes
Thu, 01/25/18 - 05:54 pm
Tags:
Biogen, M&A
Earnings Preview: What To Expect From Biogen On Thursday
Forbes
Tue, 01/23/18 - 08:45 am
Tags:
earnings, Biogen
Sanofi to Buy Biogen Hemophilia Spinoff for $11.6 Billion
Bloomberg
Mon, 01/22/18 - 11:05 am
Tags:
Sanofi, M&A, Bioverativ, Biogen, hemophilia
Whom Will Pfizer Buy in 2018?
Motley Fool
Mon, 01/22/18 - 09:42 am
Tags:
Pfizer, M&A, Biogen, Bristol-Myers Squibb, Allergan
Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows — report
Endpoints
Fri, 01/19/18 - 11:15 am
Tags:
Biogen, UCB Pharma, Acorda Therapeutics, M&A
Closing JPM18: Winners and losers, brighter days for neuroscience
Biopharma Dive
Sat, 01/13/18 - 10:58 pm
Tags:
JPMHC 2018, Neurosciences, China, Sanofi, tax reform, GSK, Biogen, Celgene, channel stuffing
Biogen Unlikely To See Spinraza Rival In 2018 As AveXis Delayed
Investors Business Daily
Fri, 01/5/18 - 05:44 pm
Tags:
Biogen, Spinraza, AveXis, AVXS-101, spinal muscular atrophy
Biogen set to raise $300M from New Year's price hikes, just enough to offset MS competition
Fierce Pharma
Thu, 01/4/18 - 12:14 am
Tags:
Biogen, MS, multiple sclerosis, drug pricing

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.